Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
From Representative to Business visionary: Private issue Victories- Huge rotating structure of galaxies and dark matter is detected
- Lebanon says Israeli strike killed 13 people near Palestinian refugee camp
- All the ways Marjorie Taylor Greene has shifted her approach lately — and why Trump is 'surprised at her'
- Met Gala 2026 will celebrate fashion as an 'embodied art form': A guide to the theme, dress code, cochairs and hosting committee of the starry event
- Sintana Energy flags major resource upgrade at Namibia oil discovery
- 5 Christmas movies to stream for less with this Paramount+ Black Friday deal
- Mars orbiter sees 'butterfly' crater spread its wings on the Red Planet
- Jesse Jackson hospitalized, under observation for a neurodegenerative condition
